These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 11564647)

  • 21. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide and central antihypertensive drugs: one more difference between catecholamines and imidazolines.
    Sy GY; Bruban V; Bousquet P; Feldman J
    Hypertension; 2001 Feb; 37(2):246-9. PubMed ID: 11230279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.
    Evans RG; Anderson WP
    Br J Pharmacol; 1995 Sep; 116(1):1557-70. PubMed ID: 8564219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central imidazoline receptors and centrally acting anti-hypertensive agents.
    Head GA; Burke SL; Chan CK
    Clin Exp Hypertens; 1997; 19(5-6):591-605. PubMed ID: 9247741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
    Prichard BN; Graham BR
    Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone.
    Sannajust F; Head GA
    Am J Cardiol; 1994 Dec; 74(13):7A-19A. PubMed ID: 7998588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.
    Chan CK; Burke SL; Zhu H; Piletz JE; Head GA
    Neuroscience; 2005; 132(4):991-1007. PubMed ID: 15857704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of alpha 2-adrenoceptors in the cardiovascular effects of moxonidine.
    Urban R; Szabo B; Starke K
    Eur J Pharmacol; 1995 Aug; 282(1-3):19-28. PubMed ID: 7498275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats.
    Estato V; Araújo CV; Bousquet P; Tibiriçá E
    Braz J Med Biol Res; 2004 Oct; 37(10):1541-9. PubMed ID: 15448876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenolol.
    Reid JL; Panfilov V; MacPhee G; Elliott HL
    Ann N Y Acad Sci; 1995 Jul; 763():673-8. PubMed ID: 7677387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethanol selectively counteracts hypotension evoked by central I(1)-imidazoline but not alpha2-adrenergic receptor activation in spontaneously hypertensive rats.
    El-Mas MM; Abdel-Rahman AA
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):382-9. PubMed ID: 9733351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.
    Vayssettes-Courchay C; Bouysset F; Cordi AA; Laubie M; Verbeuren TJ
    Br J Pharmacol; 1996 Feb; 117(3):587-593. PubMed ID: 8821553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imidazoline antihypertensive drugs: a critical review on their mechanism of action.
    Szabo B
    Pharmacol Ther; 2002 Jan; 93(1):1-35. PubMed ID: 11916539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological analysis of the cardiac sympatho-inhibitory actions of moxonidine and agmatine in pithed spontaneously hypertensive rats.
    Cobos-Puc LE; Sánchez-López A; Centurión D
    Eur J Pharmacol; 2016 Nov; 791():25-36. PubMed ID: 27565220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative importance of medullary brain nuclei for the sympatho-inhibitory actions of rilmenidine in the anaesthetized rabbit.
    Head GA; Burke SL
    J Hypertens; 1998 Apr; 16(4):503-17. PubMed ID: 9797196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
    Devoto P; Flore G; Pira L; Longu G; Gessa GL
    Eur J Pharmacol; 2004 Mar; 487(1-3):105-11. PubMed ID: 15033381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ethanol on reductions in norepinephrine electrochemical signal in the rostral ventrolateral medulla and hypotension elicited by I1-receptor activation in spontaneously hypertensive rats.
    Mao L; Li G; Abdel-Rahman AA
    Alcohol Clin Exp Res; 2003 Sep; 27(9):1471-80. PubMed ID: 14506409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between imidazoline and alpha2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents.
    Head GA; Chan CK; Burke SL
    J Auton Nerv Syst; 1998 Oct; 72(2-3):163-9. PubMed ID: 9851565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.